Vα14 NKT cell-mediated anti-tumor responses and their clinical applicationSEINO, Ken-Ichiro; FUJII, Shin-Ichiro; HARADA, Michishige et al.Springer seminars in immunopathology. 2005, Vol 27, Num 1, pp 65-74, issn 0344-4325, 10 p.Article

α-Galactosylceramide: NKT cell-based immunotherapy in intractable infectious diseasesKINJO, Yuki; KAWAKAMI, Kazuyoshi.Immunomodulators as promising therapeutic agents against infectiois diseases 2004. 2004, pp 105-122, isbn 81-7736-174-0, 18 p.Book Chapter

Ex vivo expansion of CD8⁺CD56⁺ and CD8⁺CD56^- natural killer T cells specific for MUC1 mucinWAJCHMAN, Howard J; PIERCE, Carl W; VARMA, Vijay A et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 1171-1180, issn 0008-5472, 10 p.Article

Natural killer T cells : A bridge to tolerance or a pathway to rejection?JUKES, John-Paul; WOOD, Kathryn J; JONES, Nick D et al.Transplantation. 2007, Vol 84, Num 6, pp 679-681, issn 0041-1337, 3 p.Article

Sulfatide-Reactive Natural Killer T Cells Abrogate Ischemia-Reperfusion InjurySEUNG HEE YANG; JUNG PYO LEE; HYE RYOUN JANG et al.Journal of the American Society of Nephrology. 2011, Vol 22, Num 7, pp 1305-1314, issn 1046-6673, 10 p.Article

Optimization of Natural Killer T Cell-Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector VaccinesFAVEEUW, C; TROTTEIN, F.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 6, pp 1632-1638, issn 0008-5472, 7 p.Article

Agonist Antibodies to TNFR Molecules That Costimulate T and NK CellsMELERO, Ignacio; HIRSCHHORN-CYMERMAN, Daniel; MORALES-KASTRESANA, Aizea et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 1044-1053, issn 1078-0432, 10 p.Article

Effects of cyclosporin A on the activation of natural killer T cells induced by α-galactosylceramideKAJIWARA, Takashi; TOTNITA, Yukihiro; OKANO, Shinji et al.Transplantation. 2007, Vol 83, Num 2, pp 184-192, issn 0041-1337, 9 p.Article

Innate immune responses support adaptive immunity: NKT cells induce B cell activationGALLI, Grazia; NUTI, Sandra; TAVARINI, Simona et al.Vaccine. Supplement. 2003, Vol 21, pp S2.48-S2.54, issn 1359-5938, 2Article

Clinical applications of natural killer T cell-based immunotherapy for cancerMOTOHASHI, Shinichiro; NAKAYAMA, Toshinori.Cancer science. 2008, Vol 99, Num 4, pp 638-645, issn 1347-9032, 8 p.Article

The immunoregulatory role of CD1d-restricted natural killer T cells in diseaseVAN DER VLIET, Hans J. J; MOLLING, Johan W; VON BLOMBERG, B. Mary E et al.Clinical immunology (Orlando, Fla. Print). 2004, Vol 112, Num 1, pp 8-23, issn 1521-6616, 16 p.Article

Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell FunctionOLSZAK, Torsten; AN, Dingding; BLUMBERG, Richard S et al.Science (Washington, D.C.). 2012, Vol 336, Num 6080, pp 489-493, issn 0036-8075, 5 p.Article

Requirement for Interactions of Natural Killer T Cells and Myeloid-Derived Suppressor Cells for Transplantation ToleranceHONGO, D; TANG, X; BAKER, J et al.American journal of transplantation (Print). 2014, Vol 14, Num 11, pp 2467-2477, issn 1600-6135, 11 p.Article

Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplantsHONGO, David; XIAOBIN TANG; DUTT, Suparna et al.Blood. 2012, Vol 119, Num 6, pp 1581-1589, issn 0006-4971, 9 p.Article

Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liverSUBLESKI, Jeff J; HALL, Veronica L; BACK, Timothy C et al.Cancer research (Baltimore). 2006, Vol 66, Num 22, pp 11005-11012, issn 0008-5472, 8 p.Article

The immuno-regulatory role of natural killer T cells in inflammatory disease 2005Croxford, J. L; Yamamura, T.2005, isbn 81-308-0023-3, 1Vol, 174 p., isbn 81-308-0023-3Book

Modulation of human Vα24⁺vβi I + NKT cells by age, malignancy and conventional anticancer therapiesCROUGH, T; PURDIE, D. M; OKAI, M et al.British journal of cancer. 2004, Vol 91, Num 11, pp 1880-1886, issn 0007-0920, 7 p.Article

The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cellsENGEL, Isaac; MENG ZHAO; KAPPES, Dietmar et al.Blood. 2012, Vol 120, Num 23, pp 4524-4532, issn 0006-4971, 9 p.Article

Epidermodysplasia Verruciformis Associated with Natural Killer/T Cell LymphomaBORAN, Perran; TOKUC, Gulnur; ÖZBERK, Melike et al.The Journal of pediatrics. 2010, Vol 156, Num 2, issn 0022-3476, p. 340Article

Combined natural killer T-cell-based immunotherapy eradicates established tumors in miceTENG, Michele W. L; WESTWOOD, Jennifer A; KERSHAW, Michael H et al.Cancer research (Baltimore). 2007, Vol 67, Num 15, pp 7495-7504, issn 0008-5472, 10 p.Article

Requirement for IFN-γ, CD8⁺ T lymphocytes, and NKT cells in talactoferrin-lnduced inhibition of neu⁺ tumorsSPADARO, Michela; CURCIO, Claudia; VARADHACHARY, Atul et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6425-6432, issn 0008-5472, 8 p.Article

Frequency of Vα24⁺vβ11⁺ NKT cells in peripheral blood of human kidney transplantation recipientsGALANTE, Nelson Zocoler; OZAKI, Kikumi Suzete; CENEDEZE, Marcos Antonio et al.International immunopharmacology. 2005, Vol 5, Num 1, pp 53-58, issn 1567-5769, 6 p.Article

A Novel Role for NKT Cells in Cutaneous Wound RepairSCHNEIDER, David F; PALMER, Jessica L; TULLEY, Julia M et al.The Journal of surgical research (Print). 2011, Vol 168, Num 2, pp 325-333, issn 0022-4804, 9 p.Article

CD20 expression in natural killer T cell lymphomaGILL, Harinder S; LAU, Wing-Hung; CHAN, Alexander C. L et al.Histopathology. 2010, Vol 57, Num 1, pp 157-159, issn 0309-0167, 3 p.Article

Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomasSHUSTOV, Andrei R; GOOLEY, Theodore A; MALONEY, David G et al.British journal of haematology. 2010, Vol 150, Num 2, pp 170-178, issn 0007-1048, 9 p.Article